RBC Capital raises Corteva stock price target to $86 on Q2 beat\n\nInvesting.com - RBC Capital raised its price target on Corteva Inc. (NYSE:CTVA) to $86.00 from $85.00 on Monday, while maintaining an Outperform rating on the agricultural chemical and seed company. According to InvestingPro data, the stock currently trades at $71.88, with analysts’ targets ranging from $60 to $92.\n\nThe price target adjustment follows Corteva’s strong second-quarter performance, which exceeded expectations with an EBITDA beat of approximately $164 million, representing about 8% above forecasts. The company’s last twelve months EBITDA stands at $3.57 billion, with InvestingPro analysis indicating an overall 'GOOD' financial health score.\n\nDespite the strong quarterly results, Corteva only raised the high end of its fiscal year 2025 guidance by approximately $50 million, citing potential volume uncertainty in Latin America during the second half of the year.\n\nRBC Capital noted several positive factors supporting its outlook, including solid order books, improving net royalties, margin benefits from cost reductions, and strong performance from new products. The firm indicated Corteva remains on track to achieve its 2027 target of $1 billion in EBITDA growth.\n\nThe investment bank adjusted its quarterly and annual EBITDA estimates for Corteva, revising its Q3 forecast to -$115 million from -$100 million, while raising its full-year 2025 estimate to $3,825 million from $3,780 million and its 2026 projection to $4,150 million from $4,100 million. The company currently maintains a moderate debt level with a healthy current ratio of 1.68, suggesting strong operational flexibility.\n\nIn other recent news, Corteva Inc. reported strong financial results for the second quarter of 2025, surpassing analysts’ expectations with an earnings per share of $2.20, higher than the forecasted $1.89. The company also exceeded revenue forecasts, reporting $6.54 billion against the expected $6.27 billion. Following these results, Oppenheimer reiterated its Outperform rating on Corteva, maintaining a price target of $87.00, noting the company’s strong second-quarter performance. Oppenheimer highlighted Corteva’s focus on stabilizing Crop Protection dynamics in Latin America and anticipated mid-single-digit acreage growth for the second half of the year.\n\nAdditionally, KeyBanc raised its price target for Corteva to $85 from $84, while maintaining an Overweight rating due to strong execution across all business segments. Corteva’s Seed price and volume increased by 3%, and Crop Protection volumes grew by 11%, contributing to first-half results that exceeded expectations. The company’s EBITDA is on track to grow approximately 14% this year. These developments underscore Corteva’s robust performance in recent months.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

RBC Capital Raises Corteva Stock Price Target to $86 on Q2 Beat

RBC Capital raised its price target for Corteva Inc. (CTVA) to $86.00 from $85.00, maintaining an Outperform rating, following the company's strong second-quarter 2025 performance that exceeded earnings and revenue forecasts. Corteva reported an EBITDA beat of $164 million, earnings per share of $2.20 (vs. $1.89 forecast), and revenue of $6.54 billion (vs. $6.27 billion expected). The company also raised its full-year 2025 EBITDA guidance to $3.825 billion and projected $4.15 billion for 2026. Analysts note solid order books, margin improvements, and strong new product performance, though volume uncertainty in Latin America remains a concern. Oppenheimer and KeyBanc also adjusted their targets, with Oppenheimer maintaining $87.00 and KeyBanc raising to $85.00. Corteva’s EBITDA is on track for 14% growth this year and remains on course to reach a $1 billion EBITDA growth target by 2027.